Radiative and Collisional Jet Energy Loss in a Quark-Gluon Plasma

We calculate radiative and collisional energy loss of hard partons traversing the quark-gluon plasma created at RHIC and compare the respective size of these contributions. We employ the AMY formalism for radiative energy loss and include additionally energy loss by elastic collisions. Our treatment of both processes is complete at leading order in the coupling, and accounts for the probabilistic nature of jet energy loss. We find that a solution of the Fokker-Planck equation for the probability density distributions of partons is necessary for a complete calculation of the nuclear modification factor $R_{AA}$ for pion production in heavy ion collisions. It is found that the magnitude of $R_{AA}$ is sensitive to the inclusion of both collisional and radiative energy loss, while the average energy is less affected by the addition of collisional contributions. We present a calculation of $R_{AA}$ for $\pi^0$ at RHIC, combining our energy loss formalism with a relativistic (3+1)-dimensional hydrodynamic description of the thermalized medium.Comment: 4 pages, 4 figures, contributed to Quark Matter 2008, Jaipur, Indi

Radiative and Collisional Energy Loss, and Photon-Tagged Jets at RHIC

The suppression of single jets at high transverse momenta in a quark-gluon plasma is studied at RHIC energies, and the additional information provided by a photon tag is included. The energy loss of hard jets traversing through the medium is evaluated in the AMY formalism, by consistently taking into account the contributions from radiative events and from elastic collisions at leading order in the coupling. The strongly-interacting medium in these collisions is modelled with (3+1)-dimensional ideal relativistic hydrodynamics. Putting these ingredients together with a complete set of photon-production processes, we present a calculation of the nuclear modification of single jets and photon-tagged jets at RHIC.Comment: 4 pages, 4 figures, contributed to the 3rd International Conference on Hard and Electro-Magnetic Probes of High-Energy Nuclear Collisions (Hard Probes 2008), typos corrected, published versio

Balance Functions, Correlations, Charge Fluctuations and Interferometry

Connections between charge balance functions, charge fluctuations and correlations are presented. It is shown that charge fluctuations can be directly expressed in terms of a balance functions under certain assumptions. The distortion of charge balance functions due to experimental acceptance is discussed and the effects of identical boson interference is illustrated with a simple model.Comment: 1 eps figure included. 5 pages in revtex

Performance of a prototype active veto system using liquid scintillator for a dark matter search experiment

We report the performance of an active veto system using a liquid scintillator with NaI(Tl) crystals for use in a dark matter search experiment. When a NaI(Tl) crystal is immersed in the prototype detector, the detector tags 48% of the internal K-40 background in the 0-10 keV energy region. We also determined the tagging efficiency for events at 6-20 keV as 26.5 +/- 1.7% of the total events, which corresponds to 0.76 +/- 0.04 events/keV/kg/day. According to a simulation, approximately 60% of the background events from U, Th, and K radioisotopes in photomultiplier tubes are tagged at energies of 0-10 keV. Full shielding with a 40-cm-thick liquid scintillator can increase the tagging efficiency for both the internal K-40 and external background to approximately 80%.Comment: Submitted to Nuclear Instruments and Methods in Physics Research Section

The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.

BackgroundPancreatic cancer has poor prognosis and existing interventions provide a modest benefit. Statin has anti-cancer properties that might enhance survival in pancreatic cancer patients. We sought to determine whether statin treatment after cancer diagnosis is associated with longer survival in those with pancreatic ductal adenocarcinoma (PDAC).MethodsWe analyzed data on 7813 elderly patients with PDAC using the linked Surveillance, Epidemiology, and End Results (SEER) - Medicare claims files. Information on the type, intensity and duration of statin use after cancer diagnosis was extracted from Medicare Part D. We treated statin as a time-dependent variable in a Cox regression model to determine the association with overall survival adjusting for follow-up, age, sex, race, neighborhood income, stage, grade, tumor size, pancreatectomy, chemotherapy, radiation, obesity, dyslipidemia, diabetes, chronic pancreatitis and chronic obstructive pulmonary disease (COPD).ResultsOverall, statin use after cancer diagnosis was not significantly associated with survival when all PDAC patients were considered (HR = 0.94, 95%CI 0.89, 1.01). However, statin use after cancer diagnosis was associated with a 21% reduced hazard of death (Hazard ratio = 0.79, 95% confidence interval (CI) 0.67, 0.93) in those with grade I or II PDAC and to a similar extent in those who had undergone a pancreatectomy, in those with chronic pancreatitis and in those who had not been treated with statin prior to cancer diagnosis.ConclusionsWe found that statin treatment after cancer diagnosis is associated with enhanced survival in patients with low-grade, resectable PDAC